These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 28769027)
1. Synergistic Effect of Notch-3-Specific Inhibition and Paclitaxel in Non-Small Cell Lung Cancer (NSCLC) Cells Via Activation of The Intrinsic Apoptosis Pathway. He F; Du T; Jiang Q; Zhang Y Med Sci Monit; 2017 Aug; 23():3760-3769. PubMed ID: 28769027 [TBL] [Abstract][Full Text] [Related]
2. Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells. Kang H; Jeong JY; Song JY; Kim TH; Kim G; Huh JH; Kwon AY; Jung SG; An HJ Mol Carcinog; 2016 Jul; 55(7):1196-209. PubMed ID: 26207830 [TBL] [Abstract][Full Text] [Related]
3. Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer. Sakakibara-Konishi J; Ikezawa Y; Oizumi S; Kikuchi J; Kikuchi E; Mizugaki H; Kinoshita I; Dosaka-Akita H; Nishimura M Int J Clin Oncol; 2017 Apr; 22(2):257-268. PubMed ID: 27816990 [TBL] [Abstract][Full Text] [Related]
4. Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine. Hu BD; Guo J; Ye YZ; Du T; Cheng CS; Jiang Q; Liu RN; Zhang YB Oncol Rep; 2018 Jul; 40(1):155-164. PubMed ID: 29781034 [TBL] [Abstract][Full Text] [Related]
5. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases. Yang X; Zhang Y; Huang Y; Wang Y; Qi X; Su T; Lu L Phytomedicine; 2020 Mar; 68():153176. PubMed ID: 32045841 [TBL] [Abstract][Full Text] [Related]
6. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro. Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123 [TBL] [Abstract][Full Text] [Related]
8. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer. Ikezawa Y; Sakakibara-Konishi J; Mizugaki H; Oizumi S; Nishimura M Int J Clin Oncol; 2017 Feb; 22(1):59-69. PubMed ID: 27553958 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway. Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165 [TBL] [Abstract][Full Text] [Related]
11. Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer. Ma Y; Li M; Si J; Xiong Y; Lu F; Zhang J; Zhang L; Zhang P; Yang Y Int J Oncol; 2016 Jun; 48(6):2349-58. PubMed ID: 27035162 [TBL] [Abstract][Full Text] [Related]
12. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC. Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687 [TBL] [Abstract][Full Text] [Related]
13. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth. Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729 [TBL] [Abstract][Full Text] [Related]
14. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway. You J; Cheng J; Yu B; Duan C; Peng J Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297 [TBL] [Abstract][Full Text] [Related]
15. Gambogic Acid Induces Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells by Suppressing Notch Signaling. Zhu M; Wang M; Jiang Y; Wu H; Lu G; Shi W; Cong D; Song S; Liu K; Wang H Med Sci Monit; 2018 Oct; 24():7146-7151. PubMed ID: 30293083 [TBL] [Abstract][Full Text] [Related]
16. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non-small cell lung cancer cells via Nrf2 inhibition. Chen X; Wu Q; Chen Y; Zhang J; Li H; Yang Z; Yang Y; Deng Y; Zhang L; Liu B Br J Pharmacol; 2019 Jun; 176(12):2079-2094. PubMed ID: 30825187 [TBL] [Abstract][Full Text] [Related]
17. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins. Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of role of Notch3 signaling pathway in human lung cancer cells. Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models. Gao ZW; Zhang DL; Guo CB Curr Cancer Drug Targets; 2010 Nov; 10(7):705-15. PubMed ID: 20578985 [TBL] [Abstract][Full Text] [Related]
20. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo. Chen S; Zhang Z; Zhang J Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158 [No Abstract] [Full Text] [Related] [Next] [New Search]